Cost-effectiveness analysis of exemestane versus chemotherapy in post-menopausal hormonal responsive advanced breast cancer patients

被引：0
|
作者：
Sripan, P. [1 ]
Chitapanarux, I. [2 ]
Sruamsiri, R. [3 ]
Klunklin, P. [2 ]
机构：
[1] Chiang Mai Univ, Northern Thai Res Ctr Radiat Oncol, Fac Med, Chiang Mai, Thailand
[2] Chiang Mai Univ, Div Radiat Oncol, Dept Radiol, Fac Med, Chiang Mai, Thailand
[3] Naresuan Univ, Fac Pharmaceut Sci, Ctr Pharmaceut Outcomes Res, Dept Pharm Practice, Phitsanulok, Thailand
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
105P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Cost Effectiveness of Exemestane versus Tamoxifen in Post-Menopausal Women with Early Breast Cancer in Germany
    Braun, Sebastian
    Mittendorf, Thomas
    Menschik, Thomas
    Greiner, Wolfgang
    von der Schulenburg, Johann-Matthias
    BREAST CARE, 2009, 4 (06) : 389 - 396
  • [2] Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany
    Braun, S.
    Mittendorf, T.
    Greiner, W.
    Dopatka, J.
    von der Schulenburg, J. M.
    VALUE IN HEALTH, 2007, 10 (06) : A326 - A326
  • [3] Exemestane for Chemoprevention of Breast Cancer in post-menopausal Women
    Richter-Ehrenstein, C.
    ONKOLOGE, 2011, 17 (09): : 834 - +
  • [4] Cost-effectiveness analysis review of exemestane in the treatment of primary and advanced breast cancer
    Hashemi-Meshkini, Amir
    Keshavarz, Khosro
    Gharibnaseri, Zahra
    Kheirandish, Mehrnaz
    Kebriaeezadeh, Abbas
    Nikfar, Shekoufeh
    Abdollahi, Mohammad
    ARCHIVES OF MEDICAL SCIENCE, 2013, 9 (03) : 472 - 478
  • [5] Cost-effectiveness analysis of exemestane compared with megestrol in patients with advanced breast carcinoma
    Hillner, BE
    Radice, D
    CANCER, 2001, 91 (03) : 484 - 489
  • [6] Margetuximab Versus Trastuzumab in Patients With Advanced Breast Cancer: A Cost-effectiveness Analysis
    Kelly, Bridget N.
    Webster, Alexandra J.
    Lamb, Leslie
    Spivey, Tara
    Korotkin, Jenna E.
    Henriquez, Anthony
    Gadd, Michele A.
    Hughes, Kevin S.
    Lehman, Constance R.
    Smith, Barbara L.
    Specht, Michelle C.
    CLINICAL BREAST CANCER, 2022, 22 (05) : E700 - E707
  • [7] COST-EFFECTIVENESS OF TREATMENT FOR POST-MENOPAUSAL OSTEOPOROSIS IN BRAZIL
    Brandao, C. M. R.
    Machado, G. P. D. M.
    Saturnino, L. T. M.
    Oliveira, G. L. A. D.
    Acurcio, F. D. A.
    VALUE IN HEALTH, 2013, 16 (07) : A717 - A717
  • [8] A COST-EFFECTIVENESS ANALYSIS OF DENOSUMAB FOR THE TREATMENT OF POST-MENOPAUSAL OSTEOPOROSIS IN GREECE
    Athanasakis, K.
    Karampli, E.
    Hollandezos, M.
    Papagiannopoulou, V
    Badamgarav, E.
    Intorcia, M.
    Kyriopoulos, J.
    VALUE IN HEALTH, 2011, 14 (07) : A308 - A308
  • [9] COST-EFFECTIVENESS COMPARATIVE ANALYSIS OF BISPHOSPHONATES FOR THE TREATMENT OF POST-MENOPAUSAL OSTEOPOROSIS
    Ousterhout, M. M.
    Blaser, D. A.
    Gagnon, J.
    VALUE IN HEALTH, 2010, 13 (03) : A127 - A127
  • [10] A Bayesian analysis of bisphosphonate effects and cost-effectiveness in post-menopausal osteoporosis
    Aursnes, I
    Storvik, G
    Gåsemyr, J
    Natvig, B
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2000, 9 (06) : 501 - 509
12345